[Functional and motor gastrointestinal disorders]

Gastroenterol Hepatol. 2015 Sep:38 Suppl 1:3-12. doi: 10.1016/S0210-5705(15)30014-5.
[Article in Spanish]

Abstract

This article discusses the most interesting studies on functional and motor gastrointestinal disorders presented at Digestive Diseases Week (DDW), 2015. Researchers are still seeking biomarkers for irritable bowel syndrome and have presented new data. One study confirmed that the use of low-dose antidepressants has an antinociceptive effect without altering the psychological features of patients with functional dyspepsia. A contribution that could have immediate application is the use of transcutaneous electroacupuncture, which has demonstrated effectiveness in controlling nausea in patients with gastroparesis. New data have come to light on the importance of diet in irritable bowel syndrome, although the effectiveness of a low-FODMAP diet seems to be losing momentum with time. Multiple data were presented on the long-term efficacy of rifaximin therapy in patients with irritable bowel syndrome and diarrhoea. In addition, among other contributions, and more as a curiosity, a study evaluated the effect of histamine in the diet of patients with irritable bowel syndrome.

Keywords: Dispepsia funcional; Estreñimiento funcional; Functional constipation; Functional dyspepsia; Functional gastrointestinal disorders; Gastroparesia; Gastroparesis; Irritable bowel syndrome; Síndrome del intestino irritable; Trastornos funcionales digestivos.

Publication types

  • Review

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Biomarkers
  • Constipation / physiopathology
  • Constipation / psychology
  • Constipation / therapy
  • Diarrhea / physiopathology
  • Diarrhea / psychology
  • Diarrhea / therapy
  • Dietary Carbohydrates / adverse effects
  • Dietary Fiber / therapeutic use
  • Diverticulitis / prevention & control
  • Dyspepsia / drug therapy
  • Dyspepsia / physiopathology
  • Dyspepsia / psychology
  • Electroacupuncture
  • Fermentation
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Diseases* / physiopathology
  • Gastrointestinal Diseases* / psychology
  • Gastrointestinal Diseases* / therapy
  • Gastrointestinal Motility* / physiology
  • Gastroparesis / pathology
  • Gastroparesis / physiopathology
  • Gastroparesis / therapy
  • Histamine / adverse effects
  • Humans
  • Interstitial Cells of Cajal / pathology
  • Irritable Bowel Syndrome / diet therapy
  • Irritable Bowel Syndrome / drug therapy
  • Irritable Bowel Syndrome / physiopathology
  • Irritable Bowel Syndrome / psychology
  • Randomized Controlled Trials as Topic
  • Rifamycins / therapeutic use
  • Rifaximin

Substances

  • Antidepressive Agents
  • Biomarkers
  • Dietary Carbohydrates
  • Dietary Fiber
  • Gastrointestinal Agents
  • Rifamycins
  • Histamine
  • Rifaximin